ExpreS2ion Biotechnologies is a world leading CRO specialising in developing cell lines and processes based on Drosophila S2 cells. Our company has a proprietary and complete S2 recombinant protein expression platform: ExpreS2, which was developed over ten years at Pharmexa A/S.
ExpreS2 is a uniquely successful tool for non-viral, insect cell-based expression, and we are the only service company with in-depth practical experience in its use – both in preclinical development and in clinical trials.
The ExpreS2 platform is excellent in all phases of drug discovery, R&D and manufacturing as it offers fast access to protein and easy establishment of stable polyclonal pools. This results in high protein expression levels.
Selected customers and collaboration partners
Since its inception in 2010 ExpreS2ion Biotechnologies has attracted a wide range of customers and partners. Some examples are shown below.
